Sangamo Therapeutics 10K 2019 Annual report | SGMO Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: absent, ACA, accuracy, affiliate, affiliated, alanine, ALT, aminotransferase, Andrew, Andy, AOCI, ASH, aspartate, AVV, BBA, BIG, BIMA, bioreactor, Blvd, borrowing, breakthrough, Bristol, busulfan, Cadillac, carryforward, catastrophic, CCPA, chromogenic, Circuit, classic, clonal, consequential, consummation, corroborate, cortex, cryopreserved, cryoprotectant, deletion, Delinquent, derecognized, description, deviate, device, disadvantaged, DMSO, elaborate, embedded, endpoint, entorhinal, environmental, epidemic, ESE, evenly, excipient, expiry, extraordinary, Fate, fever, Fisher, footprint, freely, FVIII, Gary, genotype, Hematology, HHS, highlight, hypersensitivity, hypotension, IBD, indel, induction, Inline, intermediate, intermittent, inventory, irrevocable, john, lee, left, Loeb, longest, lost, lowest, Lyell, mark, misfolding, Moderna, myalgia, myeloablative, NaN, neuromuscular, neutrophil, NKarta, nominate, nominated, nonhuman, nonpublic, outbreak, packed, PAH, pandemic, paper, par, phenylalanine, phenylketonuria, Pioneering, PKU, platelet, Pound, PRBC, primate, prompt, PTA, PTE, pursuit, pyrexia, Ramelmeier, recalculation, reclassified, reconstitution, recurrent, relinquish, remanded, remediation, renamed, resale, RMAT, Rolf, rolling, sample, Sana, shortage, Simplifying, Squibb, STAAR, standstill, STEADFAST, stereotaxic, Sterling, suited, sung, surrogate, tachycardia, tariff, taste, TD, TDT, telephone, text, Thermo, thought, transfused, transfusion, transient, transported, turnover, unachieved, unconstitutional, undisclosed, undiscounted, version, widespread, word, WT, XBRL, ZYNTEGLO

Removed: abnormal, accomplished, acquirer, agent, aid, altered, anemia, aroused, Asia, ATM, attenuated, authoritative, bank, belief, birth, BMT, bone, breaking, breeding, CAG, cancelable, capability, cardiovascular, CDC, cDNA, characterized, clot, clouding, cognition, cognitive, cognitively, collectability, comprise, conformance, construct, continual, core, corneal, crescent, cultivate, damaging, declined, deficiency, degradation, degrade, depreciate, dermatan, determinable, developmental, differential, disclaimer, driven, dysfunction, easily, edward, efficient, element, enabled, enhancement, enlarged, enterprise, ERT, execute, feasible, Federation, flowing, focusing, Foundation, fragile, Gaucher, globin, governance, Graft, greatly, GvHD, Harmonisation, hearing, heart, Host, HSCT, Hurler, hydroxyurea, ICH, IDS, IDUA, immunotherapy, inherit, injured, inserted, intention, interrupt, iron, irreversible, isolated, Juno, knockout, lab, lacking, landlord, leaving, lessor, line, liver, lysosomal, male, mammalian, manifest, marrow, memory, mento, mild, milder, mortality, motivate, muscle, neurologic, Notwithstanding, onset, outsourcing, overload, owner, oxygen, pain, painful, pediatric, percent, peripheral, permanent, persuasive, plasma, prevalent, principle, progression, progressive, promoter, publication, published, qualitative, RAC, recycling, regular, repeat, repeated, reproducible, residual, retrospectively, revised, scarcity, Scheie, sentiment, shape, shell, shown, simply, skeletal, somatic, sooner, spectrum, spleen, standing, steven, stimulate, stream, stretch, stroke, structured, stuck, stunted, substance, successor, sulfate, survival, survive, switch, TI, toxic, trait, transcriptional, twelve, unchanged, unwanted, USPTO, validate, VII, weekly, weighted


1			Registration Statements (Forms S-8 No. 333-166220, 333-189621, 333-206173, 333-221827, and 333-225552) pertaining to the Amended and Restated 2013 Stock Incentive Plan, 2010 Employee Stock Purchase Plan, and 2018 Equity Incentive Plan of Sangamo Therapeutics, Inc., and

2			Registration Statements (Forms S-3 No. 333-218294 and 333-224418) and related prospectuses of Sangamo Therapeutics, Inc.;

Sangamo Therapeutics (SGMO) 10-K2019 FY Annual report

Content analysis